Khaled Sanber

6PUBLICATIONS
68CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 20, 2026
Bridging the Gap: Induction Nivolumab Before Chemoradiation in Intermediate/High-Risk Human Papillomavirus-Driven Oropharyngeal Squamous Cell Carcinoma.

Malu Viter da Rosa Barbosa, Khaled Sanber

|Feb 20, 2025
A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function.

Daniel Landi, Shoba A Navai, Rebecca M Brock

|Nov 15, 2024
Divergent Clinical and Immunologic Outcomes Based on STK11 Co-mutation Status in Resectable KRAS-Mutant Lung Cancers Following Neoadjuvant Immune Checkpoint Blockade.

Samuel Rosner, Sydney Connor, Khaled Sanber

|Apr 24, 2024
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial.

Meenakshi Hegde, Shoba Navai, Christopher DeRenzo

|Aug 04, 2023
Outpatient CD28-costimulated CAR T-cells for B-cell malignancies with CNS involvement.

Khaled Sanber, Andrew Ly, Angela Ondo

Pageof 1